Urodynamic Systems in California

Bright Uro Inc. manufactures the Glean® Urodynamics System, a wireless, catheter-free urodynamic monitoring device designed to diagnose and assess lower urinary tract conditions including overactive bladder, urinary incontinence, and neurogenic bladder. The Glean system represents a significant departure from conventional urodynamics testing by eliminating invasive catheters while maintaining diagnostic accuracy. The device features wireless connectivity, cloud-based data management, and a streamlined digital workflow suitable for deployment in any clinic or exam room setting. Clinical evidence suggests Glean enhances symptom reproduction compared to conventional urodynamic studies (UDS), where catheter-induced artifact causes up to 46% symptom non-reproduction. The system is positioned for urology practices, hospital urology departments, and specialized continence/neurogenic bladder clinics. Bright Uro targets the approximately 80 million US adults with lower urinary tract symptoms, addressing unmet needs in diagnostic accessibility, patient comfort, and clinician confidence. The company emphasizes modular design, ease of clinician training, and reduced in-office time. No specific FDA clearance status, manufacturing location, or ISO certifications are stated on the website.

Teleflex Interventional Urology, operating under the UroLift brand, manufactures and markets the UroLift™ System, a minimally invasive medical device for the treatment of benign prostatic hyperplasia (BPH) in men. The UroLift System uses tiny permanent implants placed via cystoscopy to mechanically lift and hold obstructed prostate tissue away from the urethra, restoring normal urine flow without cutting, heating, or removing prostate tissue. FDA-cleared in 2013, the system is performed as an outpatient procedure under local anesthesia with typical treatment time of 1–2 hours and rapid symptom relief within days. Clinical data demonstrate superior outcomes compared to medication therapy, with no instances of new sustained erectile or ejaculatory dysfunction—a key differentiator from traditional surgical approaches. The device is covered by Medicare and major commercial insurance plans when medical criteria are met. Over 500,000 patients worldwide have been treated with UroLift. The company also provides patient education, physician training, reimbursement support, and a physician finder service. Headquartered in Pleasanton, California, Teleflex Interventional Urology is part of Teleflex Incorporated, a global medical device manufacturer.

Prosurg, Inc is a Silicon Valley-based privately held medical device manufacturer specializing in minimally invasive surgical products for urology and gynecology. The company develops and markets endoscopic instruments and electrosurgical accessories compatible with standard endoscopic platforms and RF generators. Primary product lines include the NeoScope family of single-use rigid and flexible video endoscopes (FDA-cleared), Salinetrode electrosurgical instruments for radiofrequency ablation, and Salinetrode Flex devices. Core applications include minimally invasive prostate surgery, abnormal uterine bleeding treatment, and other urological and gynecological disorders. The company's technology platform integrates with commercially available endoscopic systems, enabling adoption in existing OR environments without capital equipment replacement. Founded in Silicon Valley, Prosurg maintains focus on developing proprietary instruments that expand the scope of minimally invasive techniques in urological and gynecological surgery.